Over 400 pharmacies cancelled and delisted

1

Many pharmacies cancelled and delisted

According to incomplete statistics, since 2021, the Guangdong Provincial Drug Administration has issued a total of 13 announcements on the cancellation of the "Drug Business License", and the number of pharmacies that have been cancelled according to law has reached 410.

The announcement showed that the main reason for the cancellation of these companies was "license expiration and invalidation" or "enterprise application.

In fact, this phenomenon does not only occur in Guangdong.

The ultimate reason for pharmacies to withdraw from the market is the same-the problem of operating costs.

Some pharmacies with weak operating capabilities, due to high cost pressures or over-saturation of the market, continue to increase operating pressures.

The survival pressure of pharmacies is so high mainly due to two reasons, market and policy.

In fact, China's pharmacy market has become saturated.

In addition, due to the impact of the new crown pneumonia epidemic, online drug purchases are becoming more and more accepted by people, which has further changed people's consumption habits and brought a greater substantial impact on the passenger flow of physical pharmacies.

And the country's series of rectification policies are also not a small impact for small and medium pharmacies.

In November 2020, the State Food and Drug Administration issued the "Notice on Regulating the Provision and Use of Licensed Pharmacists in Drug Retail Enterprises", stating that the verified "certified" licensed pharmacists will be entered into the national licensed pharmacist registration management information system, and their registration certificates will be revoked and To be exposed, "certified" licensed pharmacists must also be included in the credit management "blacklist", and multi-departmental joint disciplinary action will be implemented.

Recently, the Shanxi Provincial Drug Administration also issued the "Notice on Printing and Distributing the Provincial Drug Circulation Supervision and Inspection Work Plan in 2021", which clearly stated that inspections should be carried out on the implementation of the "Pharmaceutical Business Quality Management Standards" by drug dealers in the province.

In recent years, Guangdong Province has also continuously issued notices of penalties for pharmacists' registration, which shows the state's seriousness in investigating such phenomena.

In addition, the licensed pharmacist policy and hierarchical management policy have a greater impact on the pharmacy industry.

At the end of 2018, the Ministry of Commerce officially issued the "Guiding Opinions on the Classification and Classification Management of National Retail Pharmacies (Draft for Solicitation of Comments)" that by 2020, the classification and classification management system of retail pharmacies in most provinces and cities across the country will be basically established.

In the face of complex market conditions, as a group, single pharmacies will not perish, but as individuals, certain single pharmacies will inevitably be eliminated by the market because they cannot keep up with the pace of industry development.

2

Contains development opportunities

Pharmacies disappeared.

For the development of pharmacies, this is not a bad ending in essence.
Single pharmacies do not have enough market volume to negotiate cooperation with upstream industries.
The procurement cost is relatively high.
In addition, there are problems with the provision of professional pharmacists such as licensed pharmacists.
Neither marketing nor professional services can compete with large chains.
The management of large chain pharmacies is more systematic, and the types of drugs backed by Dashu pharmacies can also be more diverse.

In addition, there are quite a few policies that are good for pharmacies.
For example, with the further advancement of the new medical reform policy, the policy of separating medicine will gradually be implemented.
Taking volume procurement as an example, the promotion of centralized procurement is expected to accelerate the trend of prescription outflow, and the channel value of retail pharmacies has increased significantly, especially those manufacturers that have not won the bid to pay more attention to pharmacy channels.

Some gradual liberalization of the overall medical insurance settlement for chronic disease drugs in pharmacies means that more prescriptions will flow into pharmacies.
In the short term, the policy will have limited impact on the performance of pharmacies, while in the long run, pharmacies will accelerate with the outflow of prescriptions.
Its channel value will be re-understood.

Pharmacies are an indispensable part of people’s daily lives.
From the perspective of the timeliness of medication, pharmacies that generally can meet patients’ medication timeliness to the greatest extent within 15 minutes if consumers are unable to do so, there is still considerable demand, but in the future The extent to which it develops depends on the efforts of the pharmacies.

For example, many pharmacies provide users with health services and set up outpatient clinics.
Medicines are different from other consumer products.
It is difficult to know exactly how to use symptomatic medications, medication methods, and medication contraindications.
According to research, 80% of patients need professional services and guidance.

Each industry has a certain elimination rate.
Pharmacies are essentially a pure commercial system.
Facing the complex market environment, pharmacies must change their mindset if they want to survive.